Your browser doesn't support javascript.
loading
Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study.
Chiappini, Stefania; d'Andrea, Giacomo; De Filippis, Sergio; Di Nicola, Marco; Andriola, Ileana; Bassetti, Roberta; Barlati, Stefano; Pettorruso, Mauro; Sensi, Stefano; Clerici, Massimo; Dell'Osso, Bernardo; Vita, Antonio; Martinotti, Giovanni.
Affiliation
  • Chiappini S; Department of Neurosciences, Imaging and Clinical Sciences, 'G. D'Annunzio' University, Chieti, Italy; Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, UK. Electronic address: stefaniachiappin
  • d'Andrea G; Department of Neurosciences, Imaging and Clinical Sciences, 'G. D'Annunzio' University, Chieti, Italy.
  • De Filippis S; Neuropsychiatric Clinic, Villa Von Siebenthal, Genzano di Roma, Italy.
  • Di Nicola M; Department of Neuroscience, Section of Psychiatry, Catholic University of the Sacred Heart, Rome, Italy; Department of Psychiatry, Agostino Gemelli University Policlinic IRCCS, Rome, Italy.
  • Andriola I; Aldo Moro' University, Bari, Italy.
  • Bassetti R; Department of Mental Health and Addiction Services, Niguarda Hospital, Milan, Italy.
  • Barlati S; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy; Department of Mental Health and Addiction Services, ASST Spedali Civili of Brescia, Italy.
  • Pettorruso M; Department of Neurosciences, Imaging and Clinical Sciences, 'G. D'Annunzio' University, Chieti, Italy.
  • Sensi S; Department of Neurosciences, Imaging and Clinical Sciences, 'G. D'Annunzio' University, Chieti, Italy.
  • Clerici M; University of Milano-Bicocca, Department of Mental Health and Addiction Services, ASST Monza, Italy.
  • Dell'Osso B; Department of Biomedical and Clinical Sciences Luigi Sacco and Aldo Ravelli Center for Neurotechnology and Brain Therapeutic, University of Milan, Milano, Italy.
  • Vita A; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy; Department of Mental Health and Addiction Services, ASST Spedali Civili of Brescia, Italy.
  • Martinotti G; Department of Neurosciences, Imaging and Clinical Sciences, 'G. D'Annunzio' University, Chieti, Italy; Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, UK.
Eur Neuropsychopharmacol ; 74: 15-21, 2023 09.
Article in En | MEDLINE | ID: mdl-37148637
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Substance-Related Disorders / Depressive Disorder, Major / Drug-Related Side Effects and Adverse Reactions / Depressive Disorder, Treatment-Resistant / Ketamine Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Humans Language: En Journal: Eur Neuropsychopharmacol Journal subject: PSICOFARMACOLOGIA Year: 2023 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Substance-Related Disorders / Depressive Disorder, Major / Drug-Related Side Effects and Adverse Reactions / Depressive Disorder, Treatment-Resistant / Ketamine Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Humans Language: En Journal: Eur Neuropsychopharmacol Journal subject: PSICOFARMACOLOGIA Year: 2023 Document type: Article